Skip to content
Recall Observatory FDA recall evidence

Exact FDA event identifier

Event 72361

16 recalled-product records grouped only because every row carries this exact official event ID.

Open FDA event record

Event summary

Timeline bucket
October 07, 2015
Product types
Drug
Classifications
Class II
Statuses
Terminated
Recalling firm wording
Pacific Healthcare, Inc dba B&B Pharmacy

Dossier provenance

Source snapshots represented here

  • openFDA Drug Enforcement Report-date coverage June 20, 2012–July 08, 2026 Known gap: openFDA describes 2004-present coverage, but the current export has no report-date records in this interval.

Enforcement coverage uses report dates; product initiation dates can precede those bounds. Device-enrichment coverage uses FDA event_date_initiated.

How coverage and grouping work

Complete imported group

Every recalled product in this event

16 official enforcement rows

Product dates, classifications, firms, and source wording remain attached to their individual rows. Opening this dossier never hides products that did not match a prior timeline filter.

drug · product 1 of 16

Stanozolol 200 mg/ml Injection, 20 mL vial, Rx, B & B Health Mart Pharmacy, Bellflower, CA

D-0165-2016
Recall number
D-0165-2016
Initiated
October 07, 2015
Classification
Class II
Status
Terminated
Quantity
2 vials

App-derived interpretation

Manufacturing or process control reason.manufacturing_process_control · v1.0.0
GMP violations
Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Assurance of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility

Code information

07162015@3, exp 10/14/2015, 08112015@1, exp 11/9/2015

Distribution pattern

CA and NJ

drug · product 2 of 16

Nandrolone 200 mg/ml Injection, 10 mL and 20 mL vials, Rx, B & B Health Mart Pharmacy, Bellflower, CA

D-0166-2016
Recall number
D-0166-2016
Initiated
October 07, 2015
Classification
Class II
Status
Terminated
Quantity
2-10ml vials, 1-20ml vial

App-derived interpretation

Manufacturing or process control reason.manufacturing_process_control · v1.0.0
GMP violations
Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Assurance of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility

Code information

10 ml-- 05252015@2, exp 10/23/2015; 06252015@2, exp 10/23/2015 20 mL-- 06252015@2, exp 10/23/2015

Distribution pattern

CA and NJ

drug · product 3 of 16

Testosterone Cypionate 250 mg/mL Injection, 10 mL vial, Rx, B & B Health Mart Pharmacy, Bellflower, CA

D-0167-2016
Recall number
D-0167-2016
Initiated
October 07, 2015
Classification
Class II
Status
Terminated
Quantity
3 vials

App-derived interpretation

Manufacturing or process control reason.manufacturing_process_control · v1.0.0
GMP violations
Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Assurance of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility

Code information

07282015@7, exp 10/26/2015, 07292015@6, 10/27/2015, 08252015@4, 11/23/2015

Distribution pattern

CA and NJ

drug · product 4 of 16

Testosterone prop. 200 mg/ml Injection, 10 mL vial, Rx, B & B Health Mart Pharmacy, Bellflower, CA

D-0168-2016
Recall number
D-0168-2016
Initiated
October 07, 2015
Classification
Class II
Status
Terminated
Quantity
2 vials

App-derived interpretation

Manufacturing or process control reason.manufacturing_process_control · v1.0.0
GMP violations
Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Assurance of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility

Code information

07282015@8, exp 10/26/2015, 07302015@4, exp 10/28/2015

Distribution pattern

CA and NJ

drug · product 5 of 16

PAPA+PGE1+PHENTO (30mg/20mcg/1mg/ml) Injection, 5 mL and 10 mL vials, Rx, B & B Health Mart Pharmacy, Bellflower, CA

D-0169-2016
Recall number
D-0169-2016
Initiated
October 07, 2015
Classification
Class II
Status
Terminated
Quantity
31 -10 ml vials; 16- 5 ml vials

App-derived interpretation

Manufacturing or process control reason.manufacturing_process_control · v1.0.0
GMP violations
Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Assurance of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility

Code information

5 mL 06022015@11, exp 11/29/2015; 06082015@5, exp 12/5/2015; 06112015@7, exp 12/8/2015; 06112015@9, exp 12/8/2015; 06162015@7, exp 12/13/2015; 07092015@6, exp 1/5/2016; 07092015@7, exp 1/5/2016; 07162015@4, exp 1/12/2016; 07202015@1, exp 1/16/2016; 07202015@2, exp 1/16/2016; 08032015@6, exp 1/30/2016; 08142015@12, exp 2/10/2016; 08142015@13, exp 2/10/2016; 08142015@7, exp 2/10/2016; 08182015@14, exp 2/14/2016; 08242015@6, exp 2/20/2016 --- 10 mL 05042015@4, exp 10/31/2015; 06012015@6, exp 11/28/2015; 06022015@12, exp 11/29/2015; 06032015@5, exp 11/30/2015; 06082015@4, exp 12/5/2015; 06082015@5, exp 12/5/2015; 06112015@4, exp 12/8/2015; 06152015@10, exp 12/12/2015; 06162015@6, exp 12/13/2015; 06232015@12, exp 12/20/2015; 07012015@1, exp 12/28/2015; 07092015@8, exp 1/5/2016; 07132015@2, exp 1/9/2016; 07152015@10, exp 1/11/2016; 07162015@6, exp 1/12/2016; 07272015@4, exp 1/23/2016; 07282015@3, exp 1/24/2016; 07282015@4, exp 1/24/2016; 07282015@5, exp 1/24/2016; 07292015@4, exp1/25/2016; 08032015@2, exp 1/30/2016; 08032015@7, exp 1/30/2016; 08142015@10, exp 2/10/2016; 08142015@11, exp 2/10/2016; 08142015@2, exp 2/10/2016; 08142015@4, exp 2/10/2016; 08142015@6, exp 2/10/2016; 08142015@8, exp 2/10/2016; 08182015@12, exp 2/14/2016; 08182015@13, exp 2/14/2016; 08312015@4, exp 2/20/2016

Distribution pattern

CA and NJ

drug · product 6 of 16

PAPA/PHENTO (30mg/1mg/ml) Injection, 5 mL and 10 mL vials, Rx, B & B Health Mart Pharmacy, Bellflower, CA

D-0170-2016
Recall number
D-0170-2016
Initiated
October 07, 2015
Classification
Class II
Status
Terminated
Quantity
1-5 ml vial, 3-10 ml vial

App-derived interpretation

Manufacturing or process control reason.manufacturing_process_control · v1.0.0
GMP violations
Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Assurance of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility

Code information

5 ml --- 07212015@2, exp 1/17/2016; 10 ml --- 05062015@17, exp 11/2/2015; 07082015@10, exp 1/4/2016; 08312015@3, exp 2/20/2016

Distribution pattern

CA and NJ

drug · product 7 of 16

PGE 20mcg/ml Injection, 10 mL vial, Rx, B & B Health Mart Pharmacy, Bellflower, CA

D-0171-2016
Recall number
D-0171-2016
Initiated
October 07, 2015
Classification
Class II
Status
Terminated
Quantity
3 vials

App-derived interpretation

Manufacturing or process control reason.manufacturing_process_control · v1.0.0
GMP violations
Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Assurance of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility

Code information

05072015@7, exp 11/3/2015; 05182015@3, 11/14/2015; 07152015@, 1/11/2016

Distribution pattern

CA and NJ

drug · product 8 of 16

PAPA/PGE1/PHENTO (30mg/50mcg/0.5mg/ml), Injection, 10 mL vial, Rx, B & B Health Mart Pharmacy, Bellflower, CA

D-0172-2016
Recall number
D-0172-2016
Initiated
October 07, 2015
Classification
Class II
Status
Terminated
Quantity
1 vial

App-derived interpretation

Manufacturing or process control reason.manufacturing_process_control · v1.0.0
GMP violations
Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Assurance of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility

Code information

06012015@7, exp 11/28/2015

Distribution pattern

CA and NJ

drug · product 9 of 16

PAPA/PGE1/PHENTO (22.5mg/8.33mcg/0.833mg/ml) Injection, 10 mL vial, Rx, B & B Health Mart Pharmacy, Bellflower, CA

D-0173-2016
Recall number
D-0173-2016
Initiated
October 07, 2015
Classification
Class II
Status
Terminated
Quantity
1 vial

App-derived interpretation

Manufacturing or process control reason.manufacturing_process_control · v1.0.0
GMP violations
Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Assurance of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility

Code information

06012015@8, exp 11/28/2015

Distribution pattern

CA and NJ

drug · product 10 of 16

PAPA/PGE1/PHENTO (30mg/10mg/1mg/ml) Injection, 5 mL and 10 mL vials, Rx, B & B Health Mart Pharmacy, Bellflower, CA

D-0174-2016
Recall number
D-0174-2016
Initiated
October 07, 2015
Classification
Class II
Status
Terminated
Quantity
1-5 ml vial; 3-10 ml vials

App-derived interpretation

Manufacturing or process control reason.manufacturing_process_control · v1.0.0
GMP violations
Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Assurance of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility

Code information

5 ml --- 07062015@2, exp 1/2/2016 10 ml --- 06042015@4, exp 12/1/2015; 06052015@15, exp 12/2/2015; 07132015@3, exp 1/9/2016

Distribution pattern

CA and NJ

drug · product 11 of 16

PAPA/PGE1/PHENTO (30mg/40mcg/1mg/ml) Injection, 10 mL vial, Rx, B & B Health Mart Pharmacy, Bellflower, CA

D-0175-2016
Recall number
D-0175-2016
Initiated
October 07, 2015
Classification
Class II
Status
Terminated
Quantity
1 vial

App-derived interpretation

Manufacturing or process control reason.manufacturing_process_control · v1.0.0
GMP violations
Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Assurance of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility

Code information

07022015@3, exp 12/29/2015

Distribution pattern

CA and NJ

drug · product 12 of 16

PAPA/PGE1/PHENTO (15mg/5mcg/0.5mg/ml) Injection, 5 mL and 10 mL vials, Rx, B & B Health Mart Pharmacy, Bellflower, CA

D-0176-2016
Recall number
D-0176-2016
Initiated
October 07, 2015
Classification
Class II
Status
Terminated
Quantity
1- 5ml vial, 1- 10 ml vial

App-derived interpretation

Manufacturing or process control reason.manufacturing_process_control · v1.0.0
GMP violations
Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Assurance of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility

Code information

5 ml --- 07062015@1, exp 1/2/2016; ---- 10 ml --- 07272015@3, exp 1/23/2016

Distribution pattern

CA and NJ

drug · product 13 of 16

PGE 30mcg/ml Injection, 10 mL vials, Rx, B & B Health Mart Pharmacy, Bellflower, CA

D-0177-2016
Recall number
D-0177-2016
Initiated
October 07, 2015
Classification
Class II
Status
Terminated
Quantity
4 vials

App-derived interpretation

Manufacturing or process control reason.manufacturing_process_control · v1.0.0
GMP violations
Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Assurance of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility

Code information

07062015@8, exp 1/2/2016; 07162015@7, exp 1/12/2016; 07272015@5, exp 1/23/2016; 08142015@9, exp 2/10/2016

Distribution pattern

CA and NJ

drug · product 14 of 16

PAPA/PHENTO (15mg/0.8333mg/ml) Injection, 5 mL vial, Rx, B & B Health Mart Pharmacy, Bellflower, CA

D-0178-2016
Recall number
D-0178-2016
Initiated
October 07, 2015
Classification
Class II
Status
Terminated
Quantity
1 vial

App-derived interpretation

Manufacturing or process control reason.manufacturing_process_control · v1.0.0
GMP violations
Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Assurance of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility

Code information

07082015@4, exp 1/5/2016

Distribution pattern

CA and NJ

drug · product 15 of 16

PAPA/PGE1/PHENTO (35mg/12mcg/1.5mg/ml), Injection, 10 mL vial, Rx, B & B Health Mart Pharmacy, Bellflower, CA

D-0179-2016
Recall number
D-0179-2016
Initiated
October 07, 2015
Classification
Class II
Status
Terminated
Quantity
1 vial

App-derived interpretation

Manufacturing or process control reason.manufacturing_process_control · v1.0.0
GMP violations
Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Assurance of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility

Code information

08032015@4, exp 1/30/2016

Distribution pattern

CA and NJ

drug · product 16 of 16

PGE 25mcg/ml, Injection, 10 mL vial, Rx, B & B Health Mart Pharmacy, Bellflower, CA

D-0180-2016
Recall number
D-0180-2016
Initiated
October 07, 2015
Classification
Class II
Status
Terminated
Quantity
1 vial

App-derived interpretation

Manufacturing or process control reason.manufacturing_process_control · v1.0.0
GMP violations
Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Assurance of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility

Code information

08242015@5, exp 2/20/2016

Distribution pattern

CA and NJ